Pulmonx (LUNG) Other Non-Current Liabilities (2019 - 2022)

Pulmonx (LUNG) reported Other Non-Current Liabilities of $179000.0 for Q2 2022, little changed quarter-over-quarter from $179000.0 in Q1 2022.

Pulmonx (LUNG) Other Non-Current Liabilities (2019 - 2022) Analysis & Trends

Pulmonx (LUNG) has 4 years of Other Non-Current Liabilities data on file, last reported at $179000.0 in Q2 2022.

  • Other Non-Current Liabilities for Q2 2022 came in at $179000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2022 was $179000.0 (changed N/A YoY), and the FY2021 annual result was $179000.0, changed N/A from the prior year.
  • Other Non-Current Liabilities was little changed at $179000.0 in Q2 2022 per LUNG's latest filing, from $179000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $1.9 million in Q3 2020 and troughed at $179000.0 in Q4 2021.
  • A 4-year average of $720400.0 and a median of $179000.0 in 2021 frame the typical range for Other Non-Current Liabilities.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Pulmonx 54.38 Mn -15.37 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 179,000.00
Mar 31, 2022 179,000.00
Dec 31, 2021 179,000.00
Sep 30, 2020 1.90 Mn
Dec 31, 2019 1.17 Mn